Bone Grafts and Substitutes Market By Type (Allografts, Bone grafts substitutes, Cell based matrices) , By Application (Spinal fusion, Trauma, Joint reconstruction, Dental bone grafting, Craniomaxillofacial) By End user (Hospitals, Specialty clinics, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The bone grafts and substitutes market was valued at $2.8 billion in 2023, and is projected t%li%reach $4.4 billion by 2033, growing at a CAGR of 4.4% from 2024 t%li%2033.
Bone grafts and substitutes are devices that are used t%li%replace missing or damaged bone in various medical procedures. They play a crucial role in orthopedics and spinal surgeries. The primary purpose of bone grafts and substitutes is t%li%support the body's natural healing process by providing a scaffold for new bone growth, enhancing the repair and regeneration of bone tissue. Thus, bone grafts and substitutes serve as vital tools in modern medicine, significantly improving patient outcomes in various surgical disciplines.
The growth of the global bone grafts and substitutes market is majorly driven by alarming increase in incidence of orthopedic conditions and rise in cases of fractures and sports injuries. A study published by Wolters Kluwer, a Dutch information services company, stated that approximately tw%li%million bone grafting procedures are performed worldwide per year. Among these, 500,000 bone graft are performed annually in the U.S. alone. Moreover, surge in geriatric population significantly contributes toward the market growth. Aged individuals are highly susceptible t%li%bone-related disorders such as osteoporosis and arthritis. This is attributed t%li%the fact that minerals in bones of aged individuals start t%li%leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone harvesters. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated t%li%increase t%li%1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, shift in preference toward minimally invasive surgical techniques, which often involve bone grafts and substitutes, is notably contributing t%li%the market growth. In addition, increase in healthcare expenditure, especially in developing regions, is improving the access t%li%advanced orthopedic treatments, including bone grafting procedures, which acts as a significant driving force of the global market. However, high cost associated with bone grafting procedures and risk of immune rejection act as the key deterrent factors of the global market. On the contrary, innovations in graft materials and surgical techniques, such as the development of bioactive and synthetic bone grafts, have expanded the applications and improved the outcomes of bone grafting procedures, which are expected t%li%open new avenues for the growth of the market during the forecast period. For instance, bioactive materials, such as bioactive glass and ceramics, are gaining traction due t%li%their ability t%li%enhance bone regeneration. Moreover, in 2020, the U.S. Food and Drug Administration approved a novel synthetic bone graft substitute designed t%li%enhance bone healing in orthopedic and spinal surgeries, reflecting ongoing advancements and regulatory support in the market.
The global bone grafts and substitutes market analysis is segmented int%li%type, application, end user, and region. On the basis of type, the market is categorized int%li%allografts, bone grafts substitute, and cell-based matrices. Depending on application, it is divided int%li%spinal fusion, trauma, craniomaxillofacial surgery, joint reconstruction, and dental bone grafting. By end user, it is classified int%li%hospitals, specialty clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the bone grafts substitute segment accounted for the largest share in 2023.
Depending on application, the spinal fusion segment occupied largest bone grafts and substitutes market size in 2023, and is expected t%li%remain dominant by 2033.
By end user, the hospitals segment was the major shareholder in 2023.
Region wise, North America garnered market share in 2023, and is anticipated t%li%continue this trend during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global bone grafts and substitutes market include Arthrex, Inc, Johnson & Johnson, Medtronic plc, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Baxter International Inc., Xtant Medical Holdings, Inc., Integra LifeSciences, and Orthofix Holdings, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%sustain the intense competition and gain a strong foothold in the global market.
Additional benefits you will get with this purchase are:
By Type
Bone grafts and substitutes are devices that are used t%li%replace missing or damaged bone in various medical procedures. They play a crucial role in orthopedics and spinal surgeries. The primary purpose of bone grafts and substitutes is t%li%support the body's natural healing process by providing a scaffold for new bone growth, enhancing the repair and regeneration of bone tissue. Thus, bone grafts and substitutes serve as vital tools in modern medicine, significantly improving patient outcomes in various surgical disciplines.
The growth of the global bone grafts and substitutes market is majorly driven by alarming increase in incidence of orthopedic conditions and rise in cases of fractures and sports injuries. A study published by Wolters Kluwer, a Dutch information services company, stated that approximately tw%li%million bone grafting procedures are performed worldwide per year. Among these, 500,000 bone graft are performed annually in the U.S. alone. Moreover, surge in geriatric population significantly contributes toward the market growth. Aged individuals are highly susceptible t%li%bone-related disorders such as osteoporosis and arthritis. This is attributed t%li%the fact that minerals in bones of aged individuals start t%li%leech out, making them brittle, fragile, and easily breakable, thereby necessitating the need for bone harvesters. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated t%li%increase t%li%1.4 billion by 2030 and 2.1 billion by 2050. Furthermore, shift in preference toward minimally invasive surgical techniques, which often involve bone grafts and substitutes, is notably contributing t%li%the market growth. In addition, increase in healthcare expenditure, especially in developing regions, is improving the access t%li%advanced orthopedic treatments, including bone grafting procedures, which acts as a significant driving force of the global market. However, high cost associated with bone grafting procedures and risk of immune rejection act as the key deterrent factors of the global market. On the contrary, innovations in graft materials and surgical techniques, such as the development of bioactive and synthetic bone grafts, have expanded the applications and improved the outcomes of bone grafting procedures, which are expected t%li%open new avenues for the growth of the market during the forecast period. For instance, bioactive materials, such as bioactive glass and ceramics, are gaining traction due t%li%their ability t%li%enhance bone regeneration. Moreover, in 2020, the U.S. Food and Drug Administration approved a novel synthetic bone graft substitute designed t%li%enhance bone healing in orthopedic and spinal surgeries, reflecting ongoing advancements and regulatory support in the market.
The global bone grafts and substitutes market analysis is segmented int%li%type, application, end user, and region. On the basis of type, the market is categorized int%li%allografts, bone grafts substitute, and cell-based matrices. Depending on application, it is divided int%li%spinal fusion, trauma, craniomaxillofacial surgery, joint reconstruction, and dental bone grafting. By end user, it is classified int%li%hospitals, specialty clinics, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the bone grafts substitute segment accounted for the largest share in 2023.
Depending on application, the spinal fusion segment occupied largest bone grafts and substitutes market size in 2023, and is expected t%li%remain dominant by 2033.
By end user, the hospitals segment was the major shareholder in 2023.
Region wise, North America garnered market share in 2023, and is anticipated t%li%continue this trend during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global bone grafts and substitutes market include Arthrex, Inc, Johnson & Johnson, Medtronic plc, NuVasive, Inc., Stryker Corporation, Zimmer Biomet Holdings, Inc., Baxter International Inc., Xtant Medical Holdings, Inc., Integra LifeSciences, and Orthofix Holdings, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships t%li%sustain the intense competition and gain a strong foothold in the global market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting t%li%16 analyst hours t%li%solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent t%li%3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
- Patient/epidemiology data at country, region, global level
- Regulatory Guidelines
- Additional company profiles with specific t%li%client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- SWOT Analysis
By Type
- Allografts
- Machined allografts
- Demineralized bone matrix
- Bone grafts substitutes
- Bone morphogenic proteins (BMP)
- Synthetic bone grafts
- Cell based matrices
- Spinal fusion
- Trauma
- Joint reconstruction
- Dental bone grafting
- Craniomaxillofacial
- Hospitals
- Specialty clinics
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
- Key Market Players
- Arthrex, Inc
- Johnson & Johnson
- Medtronic plc
- NuVasive, Inc.
- Stryker Corporation
- Zimmer Biomet Holdings, Inc.
- Baxter International Inc.
- Xtant Medical Holdings, Inc.
- Integra LifeSciences
- Orthofix Holdings, Inc.
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Therapeutic Devices
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Positive airway pressure (PAP) devices
4.2.5.1. Market Size and Forecast
4.2.5.2. Continuous Positive Airway Pressure (CPAP) Devices
4.2.5.2.1. Market Size and Forecast
4.2.5.2. Bilevel PAP (BPAP) devices
4.2.5.2.1. Market Size and Forecast
4.2.5.2. Automatic positive airway pressure (APAP) devices
4.2.5.2.1. Market Size and Forecast
4.2.6. Mask
4.2.6.1. Market Size and Forecast
4.2.6.2. Nasal masks
4.2.6.2.1. Market Size and Forecast
4.2.6.2. Full-face masks
4.2.6.2.1. Market Size and Forecast
4.2.6.2. Nasal pillow masks
4.2.6.2.1. Market Size and Forecast
4.2.6.2. Oral masks
4.2.6.2.1. Market Size and Forecast
4.2.7. Ventilators
4.2.7.1. Market Size and Forecast
4.2.7.2. Adult ventilator
4.2.7.2.1. Market Size and Forecast
4.2.7.2. Infant/neonatal ventilator
4.2.7.2.1. Market Size and Forecast
4.2.8. Nebulizers
4.2.8.1. Market Size and Forecast
4.2.9. Humidifiers
4.2.9.1. Market Size and Forecast
4.2.10. Oxygen concentrators
4.2.10.1. Market Size and Forecast
4.2.10.2. Fixed oxygen concentrators
4.2.10.2.1. Market Size and Forecast
4.2.10.2. Portable oxygen concentrators
4.2.10.2.1. Market Size and Forecast
4.2.11. Inhalers
4.2.11.1. Market Size and Forecast
4.2.12. Reusable Resuscitators
4.2.12.1. Market Size and Forecast
4.2.13. Nitric oxide delivery units
4.2.13.1. Market Size and Forecast
4.2.14. Capnographs
4.2.14.1. Market Size and Forecast
4.2.15. Gas analyzers
4.2.15.1. Market Size and Forecast
4.2.16. Oxygen hoods
4.2.16.1. Market Size and Forecast
4.3. Monitoring Devices
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Pulse oximeters
4.3.5.1. Market Size and Forecast
4.3.5.2. Pediatric pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Wrist-worn pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Hand-held pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Fingertip pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Table-top/bedside pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.4. Diagnostic Devices
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.4.5. Spirometers
4.4.5.1. Market Size and Forecast
4.4.6. Polysomnography (PSG) devices
4.4.6.1. Market Size and Forecast
4.4.7. Peak flow meters
4.4.7.1. Market Size and Forecast
4.5. Consumables And Accessories
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.5.5. Disposable masks
4.5.5.1. Market Size and Forecast
4.5.6. Disposable resuscitators
4.5.6.1. Market Size and Forecast
4.5.7. Tracheostomy tubes
4.5.7.1. Market Size and Forecast
4.5.8. Nasal cannulas
4.5.8.1. Market Size and Forecast
4.5.9. Others
4.5.9.1. Market Size and Forecast
CHAPTER 5: RESPIRATORY CARE DEVICES MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Home Care
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: RESPIRATORY CARE DEVICES MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Respiratory Care Devices Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Respiratory Care Devices Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Respiratory Care Devices Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Respiratory Care Devices Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Respiratory Care Devices Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Respiratory Care Devices Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Respiratory Care Devices Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Respiratory Care Devices Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Respiratory Care Devices Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Respiratory Care Devices Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Respiratory Care Devices Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Respiratory Care Devices Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Respiratory Care Devices Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Respiratory Care Devices Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Respiratory Care Devices Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Respiratory Care Devices Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Respiratory Care Devices Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Respiratory Care Devices Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Respiratory Care Devices Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Masimo
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Fisher And Paykel Healthcare Limited.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Koninklijke Philips N.V.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Drдgerwerk AG And Co. KGaA
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Becton, Dickinson And Company
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Medtronic
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. ResMed
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Hamilton Medical
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Chart Industries
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Invacare Corporation
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Therapeutic Devices
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.2.5. Positive airway pressure (PAP) devices
4.2.5.1. Market Size and Forecast
4.2.5.2. Continuous Positive Airway Pressure (CPAP) Devices
4.2.5.2.1. Market Size and Forecast
4.2.5.2. Bilevel PAP (BPAP) devices
4.2.5.2.1. Market Size and Forecast
4.2.5.2. Automatic positive airway pressure (APAP) devices
4.2.5.2.1. Market Size and Forecast
4.2.6. Mask
4.2.6.1. Market Size and Forecast
4.2.6.2. Nasal masks
4.2.6.2.1. Market Size and Forecast
4.2.6.2. Full-face masks
4.2.6.2.1. Market Size and Forecast
4.2.6.2. Nasal pillow masks
4.2.6.2.1. Market Size and Forecast
4.2.6.2. Oral masks
4.2.6.2.1. Market Size and Forecast
4.2.7. Ventilators
4.2.7.1. Market Size and Forecast
4.2.7.2. Adult ventilator
4.2.7.2.1. Market Size and Forecast
4.2.7.2. Infant/neonatal ventilator
4.2.7.2.1. Market Size and Forecast
4.2.8. Nebulizers
4.2.8.1. Market Size and Forecast
4.2.9. Humidifiers
4.2.9.1. Market Size and Forecast
4.2.10. Oxygen concentrators
4.2.10.1. Market Size and Forecast
4.2.10.2. Fixed oxygen concentrators
4.2.10.2.1. Market Size and Forecast
4.2.10.2. Portable oxygen concentrators
4.2.10.2.1. Market Size and Forecast
4.2.11. Inhalers
4.2.11.1. Market Size and Forecast
4.2.12. Reusable Resuscitators
4.2.12.1. Market Size and Forecast
4.2.13. Nitric oxide delivery units
4.2.13.1. Market Size and Forecast
4.2.14. Capnographs
4.2.14.1. Market Size and Forecast
4.2.15. Gas analyzers
4.2.15.1. Market Size and Forecast
4.2.16. Oxygen hoods
4.2.16.1. Market Size and Forecast
4.3. Monitoring Devices
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.3.5. Pulse oximeters
4.3.5.1. Market Size and Forecast
4.3.5.2. Pediatric pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Wrist-worn pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Hand-held pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Fingertip pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.3.5.2. Table-top/bedside pulse oximeters
4.3.5.2.1. Market Size and Forecast
4.4. Diagnostic Devices
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.4.5. Spirometers
4.4.5.1. Market Size and Forecast
4.4.6. Polysomnography (PSG) devices
4.4.6.1. Market Size and Forecast
4.4.7. Peak flow meters
4.4.7.1. Market Size and Forecast
4.5. Consumables And Accessories
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.5.5. Disposable masks
4.5.5.1. Market Size and Forecast
4.5.6. Disposable resuscitators
4.5.6.1. Market Size and Forecast
4.5.7. Tracheostomy tubes
4.5.7.1. Market Size and Forecast
4.5.8. Nasal cannulas
4.5.8.1. Market Size and Forecast
4.5.9. Others
4.5.9.1. Market Size and Forecast
CHAPTER 5: RESPIRATORY CARE DEVICES MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Home Care
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: RESPIRATORY CARE DEVICES MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Product
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Respiratory Care Devices Market
6.2.5.1. Market Size and Forecast, By Product
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Respiratory Care Devices Market
6.2.6.1. Market Size and Forecast, By Product
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Respiratory Care Devices Market
6.2.7.1. Market Size and Forecast, By Product
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Product
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Respiratory Care Devices Market
6.3.5.1. Market Size and Forecast, By Product
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Respiratory Care Devices Market
6.3.6.1. Market Size and Forecast, By Product
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Respiratory Care Devices Market
6.3.7.1. Market Size and Forecast, By Product
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Respiratory Care Devices Market
6.3.8.1. Market Size and Forecast, By Product
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Respiratory Care Devices Market
6.3.9.1. Market Size and Forecast, By Product
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Respiratory Care Devices Market
6.3.10.1. Market Size and Forecast, By Product
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Product
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Respiratory Care Devices Market
6.4.5.1. Market Size and Forecast, By Product
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Respiratory Care Devices Market
6.4.6.1. Market Size and Forecast, By Product
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Respiratory Care Devices Market
6.4.7.1. Market Size and Forecast, By Product
6.4.7.2. Market Size and Forecast, By End User
6.4.8. South Korea Respiratory Care Devices Market
6.4.8.1. Market Size and Forecast, By Product
6.4.8.2. Market Size and Forecast, By End User
6.4.9. Australia Respiratory Care Devices Market
6.4.9.1. Market Size and Forecast, By Product
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Respiratory Care Devices Market
6.4.10.1. Market Size and Forecast, By Product
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Product
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Respiratory Care Devices Market
6.5.5.1. Market Size and Forecast, By Product
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Respiratory Care Devices Market
6.5.6.1. Market Size and Forecast, By Product
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Respiratory Care Devices Market
6.5.7.1. Market Size and Forecast, By Product
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Respiratory Care Devices Market
6.5.8.1. Market Size and Forecast, By Product
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Masimo
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. Fisher And Paykel Healthcare Limited.
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Koninklijke Philips N.V.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Drдgerwerk AG And Co. KGaA
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Becton, Dickinson And Company
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Medtronic
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. ResMed
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Hamilton Medical
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. Chart Industries
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Invacare Corporation
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
